switching from tirzepatide to semaglutide for maintenance Tirzepatide: A Provider's Guide Tirzepatide vs. Semaglutide: What You
Description
Amylyx updates investors on its rare disease pipeline, including avexitides Phase 3 LUCIDITY trial, AMX0035 in Wolfram syndrome, AMX0114 in ALS, and a $317M cash position with runway into 2028 through potential avexitide approval and launch in 2027.
Smits MM, Van Raalte DH
Discover the key factors to consider before starting semaglutide therapy
The Key to Crushing Your Goals
Excess weight, especially after menopause, is a major modifiable risk factor for breast cancer
